Versant Capital Management, Inc Seagen Inc. Transaction History

Versant Capital Management, Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	BUY	$187.64 - $206.25 $187 - $206	1 Added 20.0%	6 $1,000
Q1 2023 Apr 10, 2023	SELL	$127.59 - $203.08 $127 - $203	-1 Reduced 16.67%	5 $1,000
Q4 2022 Jan 25, 2023	SELL	$117.37 - $139.17 $1,408 - $1,670	-12 Reduced 66.67%	6 $0
Q1 2022 Apr 29, 2022	SELL	$119.61 - $157.85 $358 - $473	-3 Reduced 14.29%	18 $3,000
Q3 2021 Oct 29, 2021	SELL	$142.45 - $169.82 $1,709 - $2,037	-12 Reduced 36.36%	21 $4,000

Q2 2021 Jul 22, 2021	BUY	$135.08 - $161.1 $1,756 - $2,094	13 Added 65.0%	33 $5,000
Q1 2021 Apr 27, 2021	BUY	$137.51 - $190.8 $1,925 - $2,671	14 Added 233.33%	20 $3,000
Q4 2020 Feb 08, 2021	BUY	$164.63 - $211.93 $987 - $1,271	6 New	6 $1,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Versant Capital Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Versant Capital Management, Inc with notifications on news.